Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Clinical characteristics and prognostic factors of plasmablastic lymphoma patients

Dr Emmanuelle Tchernonog - CHRU Montpellier, Montpellier, France
Clinical characteristics and prognostic factors of plasmablastic lymphoma patients ( Dr Emmanuelle Tchernonog - CHRU Montpellier, Montpellier, France )
11 Jun 2016

Blinatumomab improves survival of relapsed B-cell leukaemia

Prof Max Topp - University of Würzburg, Würzburg, Germany
Blinatumomab improves survival of relapsed B-cell leukaemia ( Prof Max Topp - University of Würzburg, Würzburg, Germany )
11 Jun 2016

Decoding the risk of thromboembolic events in lymphoma patients

Prof Darko Antic - Clinic For Hematology, Clinical Center Serbia, Belgrade, Serbia
Decoding the risk of thromboembolic events in lymphoma patients ( Prof Darko Antic - Clinic For Hematology, Clinical Center Serbia, Belgrade, Serbia )
11 Jun 2016

Activated JAK-STAT signaling co-operates with HOXA9 to drive leukaemia

Dr Charles De Bock - KU Leuven, Leuven, Belgium
Activated JAK-STAT signaling co-operates with HOXA9 to drive leukaemia ( Dr Charles De Bock - KU Leuven, Leuven, Belgium )
10 Jun 2016

SL401 in patients with rare neoplasm

Prof Naveen Pemmaraju - The University of Texas MD Anderson Cancer Center, Houston, United States
SL401 in patients with rare neoplasm ( Prof Naveen Pemmaraju - The University of Texas MD Anderson Cancer Center, Houston, United States )
10 Jun 2016

RNA regulation of JAK-STAT pathways in CML

Prof Danilo Perrotti - The University of Maryland Baltimore, Baltimore, USA
RNA regulation of JAK-STAT pathways in CML ( Prof Danilo Perrotti - The University of Maryland Baltimore, Baltimore, USA )
10 Jun 2016

Pre-leukaemic clones that survive chemo linked to higher risk of AML recurrence

Dr Klaus Metzeler - Ludwig-Maximilians-Universität, Munich, Germany
Pre-leukaemic clones that survive chemo linked to higher risk of AML recurrence ( Dr Klaus Metzeler - Ludwig-Maximilians-Universität, Munich, Germany )
10 Jun 2016

Targetting PD-L1 with avelumab in metastatic Merkel cell carcinoma

Dr Howard Kaufman - Rutgers Cancer Institute of New Jersey, USA
Targetting PD-L1 with avelumab in metastatic Merkel cell carcinoma ( Dr Howard Kaufman - Rutgers Cancer Institute of New Jersey, USA )
6 Jun 2016

Ten years of letrozole improves survival and quality of life in early-diagnosed breast cancer.

Dr Julie Lemieux - Hôpital du Saint-Sacrement, Québec, Canada
Ten years of letrozole improves survival and quality of life in early-diagnosed breast cancer. ( Dr Julie Lemieux - Hôpital du Saint-Sacrement, Québec, Canada )
6 Jun 2016

Daratumumab slows progression in refractory multiple myeloma

Prof Palumbo - University of Turin, Turin, Italy
Daratumumab slows progression in refractory multiple myeloma ( Prof Palumbo - University of Turin, Turin, Italy )
6 Jun 2016

Developments in haematological malignancies

Dr Stephen Nimer - University of Miami, Miami, USA
Developments in haematological malignancies ( Dr Stephen Nimer - University of Miami, Miami, USA )
6 Jun 2016

Recent developments in targeted therapies

Dr Stephen Nimer - University of Miami, Miami, USA
Recent developments in targeted therapies ( Dr Stephen Nimer - University of Miami, Miami, USA )
6 Jun 2016